Peter Sillevis Smitt

4.2k total citations
48 papers, 2.4k citations indexed

About

Peter Sillevis Smitt is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Peter Sillevis Smitt has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Neurology and 11 papers in Genetics. Recurrent topics in Peter Sillevis Smitt's work include Autoimmune Neurological Disorders and Treatments (16 papers), Virus-based gene therapy research (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Peter Sillevis Smitt is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (16 papers), Virus-based gene therapy research (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Peter Sillevis Smitt collaborates with scholars based in Netherlands, United States and Spain. Peter Sillevis Smitt's co-authors include Martin J. van den Bent, Charles J. Vecht, B. de Leeuw, Setareh Shamsili, Herbert Hooijkaas, Bronno van der Holt, Josep Dalmau, Geoffrey T. Manley, Jerome B. Posner and C. J. J. Avezaat and has published in prestigious journals such as New England Journal of Medicine, Brain and Neurology.

In The Last Decade

Peter Sillevis Smitt

46 papers receiving 2.3k citations

Peers

Peter Sillevis Smitt
Jesús Planagumà Spain
Bastien Joubert France
Paul Maddison United Kingdom
Jean‐Christophe Antoine France
Αναστασία Ζεκερίδου United States
Terry Lichtor United States
Dusica Babovic‐Vuksanovic United States
Susan Maxwell United Kingdom
Ian Sutton Australia
Michael R. Fetell United States
Jesús Planagumà Spain
Peter Sillevis Smitt
Citations per year, relative to Peter Sillevis Smitt Peter Sillevis Smitt (= 1×) peers Jesús Planagumà

Countries citing papers authored by Peter Sillevis Smitt

Since Specialization
Citations

This map shows the geographic impact of Peter Sillevis Smitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sillevis Smitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sillevis Smitt more than expected).

Fields of papers citing papers by Peter Sillevis Smitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sillevis Smitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sillevis Smitt. The network helps show where Peter Sillevis Smitt may publish in the future.

Co-authorship network of co-authors of Peter Sillevis Smitt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sillevis Smitt. A scholar is included among the top collaborators of Peter Sillevis Smitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sillevis Smitt. Peter Sillevis Smitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leypoldt, Frank, Jérôme Honnorat, Josep Dalmau, et al.. (2023). Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis, Already at Diagnosis: The NEOS2 Model. (P5-5.009). Neurology. 100(17_supplement_2). 1 indexed citations
2.
Sonderen, Agnes van, Marco W.J. Schreurs, Rob P.W. Rouhl, et al.. (2019). Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABbR encephalitis (S11.008). Neurology. 92(15_supplement).
3.
Sonderen, Agnes van, Helena Ariño, Mar Petit‐Pedrol, et al.. (2016). The Clinical Spectrum of Caspr2-Antibody Associated Disease (S12.008). Neurology. 86(16_supplement). 2 indexed citations
4.
Erdem‐Eraslan, Lale, Ya Gao, Nanne K. Kloosterhof, et al.. (2015). Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation. European Journal of Cancer. 51(7). 893–903. 20 indexed citations
5.
Graaff, Esther de, Esther Hulsenboom, Robert van den Berg, et al.. (2012). Identification of delta/notch‐like epidermal growth factor‐related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Annals of Neurology. 71(6). 815–824. 105 indexed citations
6.
VanDuijn, Martijn M., et al.. (2012). Mass spectrometric detection of antigen-specific immunoglobulin peptides in paraneoplastic patient sera. Journal of Autoimmunity. 38(4). 354–360. 14 indexed citations
7.
Shamsili, Setareh, B. de Leeuw, Esther Hulsenboom, Dick Jaarsma, & Peter Sillevis Smitt. (2009). A new paraneoplastic encephalomyelitis autoantibody reactive with the axon initial segment. Neuroscience Letters. 467(2). 169–172. 8 indexed citations
8.
Kraan, Jaco, Martin J. van den Bent, Markus Klimek, et al.. (2008). B and T cell imbalances in CSF of patients with Hu-antibody associated PNS. Journal of Neuroimmunology. 195(1-2). 164–170. 25 indexed citations
9.
Brouwer, Eric, et al.. (2007). Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)‐selective oncolytic adenovirus. The Journal of Gene Medicine. 9(12). 1071–1079. 19 indexed citations
10.
Leeuw, B. de, Mu Su, Shingo Iwata, et al.. (2006). Increased glia‐specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements. Journal of Neuroscience Research. 83(5). 744–753. 43 indexed citations
11.
Brouwer, E., Menzo Havenga, Olga Ophorst, et al.. (2006). Human adenovirus type 35 vector for gene therapy of brain cancer: improved transduction and bypass of pre-existing anti-vector immunity in cancer patients. Cancer Gene Therapy. 14(2). 211–219. 34 indexed citations
12.
Dekker, Lennard J. M., et al.. (2004). Reproducibility of MALDI-TOF mass spectrometry measurements on complex biofluids.. Cancer Research. 64. 817–817. 2 indexed citations
13.
Shamsili, Setareh, B. de Leeuw, Martin J. van den Bent, et al.. (2003). Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain. 126(6). 1409–1418. 359 indexed citations
14.
Minami, Itsunari, Mineko Kengaku, Peter Sillevis Smitt, Ryuichi Shigemoto, & Tomoo Hirano. (2003). Long‐term potentiation of mGluR1 activity by depolarization‐induced Homer1a in mouse cerebellar Purkinje neurons. European Journal of Neuroscience. 17(5). 1023–1032. 40 indexed citations
15.
Smitt, Peter Sillevis, B. de Leeuw, Martin J. van den Bent, et al.. (2002). Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Journal of Neurology. 249(6). 745–753. 157 indexed citations
16.
Smitt, Peter Sillevis, Ayae Kinoshita, B. de Leeuw, et al.. (2000). Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor. New England Journal of Medicine. 342(1). 21–27. 309 indexed citations
17.
Smitt, Peter Sillevis, et al.. (1999). Spinal epidural abscess complicating chronic epidural analgesia in 11 cancer patients: clinical findings and magnetic resonance imaging. Journal of Neurology. 246(9). 815–820. 24 indexed citations
18.
Smitt, Peter Sillevis, et al.. (1998). Neuropsychiatric lupus?. Annals of the Rheumatic Diseases. 57(1). 9–10. 5 indexed citations
19.
Ross, Ronald, Darina L. Lazarova, Geoffrey T. Manley, et al.. (1997). HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells. European Journal of Cancer. 33(12). 2071–2074. 28 indexed citations
20.
Manley, Geoffrey T., Peter Sillevis Smitt, Josep Dalmau, & Jerome B. Posner. (1995). Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites. Annals of Neurology. 38(1). 102–110. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús Planagumà Breakdown of academic impact, for papers by Bastien Joubert Breakdown of academic impact, for papers by Paul Maddison Breakdown of academic impact, for papers by Jean‐Christophe Antoine Breakdown of academic impact, for papers by Αναστασία Ζεκερίδου Breakdown of academic impact, for papers by Terry Lichtor Breakdown of academic impact, for papers by Dusica Babovic‐Vuksanovic Breakdown of academic impact, for papers by Susan Maxwell Breakdown of academic impact, for papers by Ian Sutton Breakdown of academic impact, for papers by Michael R. Fetell
Rankless by CCL
2026